earnings
XE
NASDAQ · XENE
Xenon Pharmaceuticals Inc.
Healthcare · Biotechnology
$37.41
Up+$0.56 (+1.50%)
Updated Nov 2, 2026, 3:45 PM
SID Score
4.2/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.37B
- P/E ratio
- -12.39
- Dividend yield
- 0.00%
- 52-week range
- $33.38 – $72.66
- Volume
- 1.12M
- Avg. volume
- 790.48K
Price performance · XENE
XENE price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
XENE closed at $37.41 after 20 trading sessions, down 0.43% for the selected period.
- Last close
- $37.41
- Period change
- -0.43%
- Period low
- $33.49
- Period high
- $37.57
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $37.54 | $38.12 | $36.84 | $37.41 | 1.12M |
| Oct 29, 2026 | $37.27 | $37.685 | $36.49 | $37.54 | 1.55M |
| Oct 28, 2026 | $35.71 | $36.62 | $35.37 | $36.34 | 2.13M |
| Oct 27, 2026 | $35.61 | $36.21 | $35.3375 | $36.01 | 1.09M |
| Oct 26, 2026 | $35.34 | $35.82 | $35.09 | $35.77 | 726.71K |
| Oct 23, 2026 | $36.62 | $36.62 | $35.23 | $35.34 | 636.6K |
| Oct 22, 2026 | $35.92 | $36.90 | $35.695 | $36.50 | 1.38M |
| Oct 21, 2026 | $36.55 | $37.00 | $35.89 | $35.95 | 1.08M |
| Oct 20, 2026 | $35.14 | $36.645 | $35.10 | $36.27 | 990.76K |
| Oct 19, 2026 | $33.89 | $35.14 | $33.72 | $35.08 | 1.21M |
| Oct 16, 2026 | $34.34 | $34.375 | $33.38 | $33.49 | 1.08M |
| Oct 15, 2026 | $34.11 | $34.99 | $33.99 | $34.33 | 1.62M |
| Oct 14, 2026 | $34.12 | $34.84 | $33.52 | $33.90 | 1.79M |
| Oct 13, 2026 | $35.65 | $35.9024 | $34.38 | $34.42 | 1.11M |
| Oct 12, 2026 | $36.45 | $36.54 | $35.57 | $35.81 | 764.61K |
| Oct 9, 2026 | $36.05 | $36.70 | $35.98 | $36.44 | 1.24M |
| Oct 8, 2026 | $36.13 | $36.41 | $35.06 | $36.16 | 2.27M |
| Oct 7, 2026 | $36.19 | $36.56 | $35.78 | $36.41 | 1.97M |
| Oct 6, 2026 | $37.78 | $37.79 | $35.75 | $36.57 | 2.79M |
| Oct 5, 2026 | $38.02 | $38.225 | $37.00 | $37.57 | 1.7M |
Latest XENE news
The latest Smart Investors Daily articles mentioning XENE.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…